Antonio Verdoliva
- Molecular Biology top 10%
- Radiology, Nuclear Medicine and Imaging top 2%
- Immunology top 10%
- Oncology
- Epidemiology
- Co-authors
- Giorgio FassinaMenotti RuvoGiovanna PalomboGiovanni CassaniVincenzo RivieccioG. BaroneRita De SantisConcetta Giancola
- Topics
- Monoclonal and Polyclonal Antibodies Research (18 papers)Glycosylation and Glycoproteins Research (9 papers)Chemical Synthesis and Analysis (7 papers)
- Partner nations
- ItalySwitzerlandUnited Kingdom
In The Last Decade
Antonio Verdoliva
36 papers receiving 1.2k citations
Peers
Comparison fields: 5 of 98
- Molecular Biology 804
- Radiology, Nuclear Medicine and Imaging 633
- Immunology 320
- Oncology 85
- Epidemiology 83
Countries citing papers authored by Antonio Verdoliva
This map shows the geographic impact of Antonio Verdoliva's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Antonio Verdoliva with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Antonio Verdoliva more than expected).
Fields of papers citing papers by Antonio Verdoliva
This network shows the impact of papers produced by Antonio Verdoliva. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Antonio Verdoliva. The network helps show where Antonio Verdoliva may publish in the future.
Co-authorship network of co-authors of Antonio Verdoliva
This figure shows the co-authorship network connecting the top 25 collaborators of Antonio Verdoliva. A scholar is included among the top collaborators of Antonio Verdoliva based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Antonio Verdoliva. Antonio Verdoliva is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 10 | |
| 2 | 28 | |
| 3 | 100 | |
| 4 | 2 | |
| 5 | 14 | |
| 6 | 115 | |
| 7 | 38 | |
| 8 | 21 | |
| 9 | 20 | |
| 10 | 42 | |
| 11 | 1 | |
| 12 | 36 | |
| 13 | 4 | |
| 14 | 101 | |
| 15 | 64 | |
| 16 | Affinity purification of immunoglobulins from chicken egg yolk using a new synthetic ligand | 29 |
| 17 | 67 | |
| 18 | 97 | |
| 19 | 12 | |
| 20 | 10 |
About Antonio Verdoliva
Antonio Verdoliva is a scholar working on Radiology, Nuclear Medicine and Imaging, Immunology and Allergy and Immunology, having authored 36 papers that have together received 1.3k indexed citations. Recurring topics across this work include Monoclonal and Polyclonal Antibodies Research (18 papers), Glycosylation and Glycoproteins Research (9 papers) and Chemical Synthesis and Analysis (7 papers). The work is most often cited by research in Radiology, Nuclear Medicine and Imaging (633 citations), Immunology (320 citations) and Molecular Biology (804 citations). Antonio Verdoliva has collaborated with scholars based in Italy, Switzerland and United Kingdom. Frequent co-authors include Giorgio Fassina, Menotti Ruvo, Giovanna Palombo, Giovanni Cassani, Vincenzo Rivieccio, G. Barone, Rita De Santis, Concetta Giancola, Maria Isabel D. Rossi and Giovanni Salvatori. Their work appears in journals such as Journal of Biological Chemistry, PLoS ONE and Clinical Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.